Works matching DE "CD20 antigen"

Results: 488
    1
    2
    3
    4
    5

    Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody.

    Published in:
    Biochemical Journal, 2021, v. 478, n. 1, p. 99, doi. 10.1042/BCJ20200674
    By:
    • Uhrik, Lukas;
    • Hernychova, Lenka;
    • Muller, Petr;
    • Kalathiya, Umesh;
    • Lisowska, Malgorzata M.;
    • Kocikowski, Mikolaj;
    • Parys, Maciej;
    • Faktor, Jakub;
    • Nekulova, Marta;
    • Nortcliffe, Chris;
    • Zatloukalova, Pavlina;
    • Ruetgen, Barbara;
    • Fahraeus, Robin;
    • Ball, Kathryn L.;
    • Argyle, David J.;
    • Vojtesek, Borivoj;
    • Hupp, Ted R.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Anti-CD20 inhibits T cell-mediated pathology and microgliosis in the rat brain.

    Published in:
    Annals of Clinical & Translational Neurology, 2014, v. 1, n. 9, p. 659, doi. 10.1002/acn3.94
    By:
    • Anthony, Daniel C.;
    • Dickens, Alex M.;
    • Seneca, Nicholas;
    • Couch, Yvonne;
    • Campbell, Sandra;
    • Checa, Begona;
    • Kersemans, Veerle;
    • Warren, Edward A.;
    • Tredwell, Matthew;
    • Sibson, Nicola R.;
    • Gouverneur, Veronique;
    • Leppert, David
    Publication type:
    Article
    12
    13
    14

    Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models.

    Published in:
    Clinical & Translational Immunology, 2022, v. 11, n. 2, p. 1, doi. 10.1002/cti2.1373
    By:
    • Nishimoto, Kevin P;
    • Barca, Taylor;
    • Azameera, Aruna;
    • Makkouk, Amani;
    • Romero, Jason M;
    • Bai, Lu;
    • Brodey, Mary M;
    • Kennedy‐Wilde, Jackie;
    • Shao, Hui;
    • Papaioannou, Stephanie;
    • Doan, Amy;
    • Masri, Cynthia;
    • Hoang, Ngoc T;
    • Tessman, Hayden;
    • Ramanathan, Vidhya Dhevi;
    • Giner‐Rubio, Ana;
    • Delfino, Frank;
    • Sharma, Kriti;
    • Bray, Kevin;
    • Hoopes, Matthew
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29

    Evaluation of pediatric rheumatologists' approach to rituximab use: a questionnaire study.

    Published in:
    European Journal of Pediatrics, 2024, v. 183, n. 9, p. 3959, doi. 10.1007/s00431-024-05654-9
    By:
    • Sunar Yayla, Emine Nur;
    • Gezgin Yıldırım, Deniz;
    • Adıgüzel Dündar, Hatice;
    • Adrovic, Amra;
    • Akbörü, Elifsu Gözde;
    • Aktay Ayaz, Nuray;
    • Aliyev, Emil;
    • Avar Aydın, Pınar Özge;
    • Aydın, Fatma;
    • Baba, Özge;
    • Bağlan, Esra;
    • Bora Makay, Balahan;
    • Bozkaya Yücel, Burcu;
    • Çakan, Mustafa;
    • Çelikel, Elif;
    • Demir, Ferhat;
    • Demir, Selcan;
    • Demirkan, Fatma Gül;
    • Ekici Tekin, Zahide;
    • Esmeray Şenol, Pelin
    Publication type:
    Article
    30

    Rituximab Use and Hypogammaglobulinemia.

    Published in:
    American Journal of Case Reports, 2020, v. 21, p. 1, doi. 10.12659/AJCR.920681
    By:
    • Alhassan, Eaman;
    • Johnson, Justina;
    • Nakity, Rasha;
    • Shah, Hajra Zehra
    Publication type:
    Article
    31
    32
    33

    Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.

    Published in:
    Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01436-6
    By:
    • Chen, Jinghong;
    • Zuo, Zhixiang;
    • Gao, Yan;
    • Yao, Xiaosai;
    • Guan, Peiyong;
    • Wang, Yali;
    • Li, Zhimei;
    • Liu, Zhilong;
    • Hong, Jing Han;
    • Deng, Peng;
    • Chan, Jason Yongsheng;
    • Cheah, Daryl Ming Zhe;
    • Lim, Jingquan;
    • Chai, Kelila Xin Ye;
    • Chia, Burton Kuan Hui;
    • Pang, Jane Wan Lu;
    • Koh, Joanna;
    • Huang, Dachuan;
    • He, Haixia;
    • Sun, Yichen
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44

    Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 4, p. 663, doi. 10.1002/hon.3174
    By:
    • Birtas Atesoglu, Elif;
    • Gulbas, Zafer;
    • Uzay, Ant;
    • Ozcan, Muhit;
    • Ozkalemkas, Fahir;
    • Dal, Mehmet Sinan;
    • Kalyon, Hakan;
    • Akay, Olga Meltem;
    • Deveci, Burak;
    • Bekoz, Huseyin;
    • Sevindik, Omur Gokmen;
    • Toptas, Tayfur;
    • Yilmaz, Fergun;
    • Koyun, Derya;
    • Alkis, Nihan;
    • Alacacioglu, Inci;
    • Sonmez, Mehmet;
    • Yavasoglu, Irfan;
    • Tombak, Anil;
    • Mehtap, Ozgur
    Publication type:
    Article
    45

    NATHALI‐01: A PHASE 1/2A TRIAL OF UCART20X22, AN ALLOGENEIC DUAL CAR T‐CELL THERAPY FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN LYMPHOMA (NHL).

    Published in:
    Hematological Oncology, 2023, v. 41, p. 825, doi. 10.1002/hon.3166_OT08
    By:
    • Bachy, E.;
    • Ramakrishnan, A.;
    • Thieblemont, C.;
    • Alfonso, A.;
    • Braunschweig, I.;
    • Riedell, P. A.;
    • Cartron, G.;
    • Barba, P.;
    • Gastinne, T.;
    • Simon, J. A. Perez;
    • Solano, C.;
    • Meadows, S.;
    • LaCroce, A.;
    • Thomas, D.;
    • Poirot, C.;
    • Newhall, K. J.;
    • Lee, D. J.;
    • Frattini, M. G.;
    • Abramson, J.
    Publication type:
    Article
    46
    47
    48

    HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL.

    Published in:
    Hematological Oncology, 2023, v. 41, p. 87, doi. 10.1002/hon.3163_49
    By:
    • Shadman, M.;
    • Yeung, C.;
    • Redman, M.;
    • Lee, S. Y.;
    • Lee, D. H.;
    • Qian, D. H.;
    • Ra, S.;
    • Ujjani, C. S.;
    • Dezube, B. J.;
    • Warren, E. H.;
    • Chapuis, A. G.;
    • Green, D. J.;
    • Cowan, A. J.;
    • Cassaday, R. D.;
    • Kiem, H.;
    • Poh, C.;
    • Smith, S. D.;
    • Milano, F.;
    • Gauthier, J.;
    • Hirayama, A. V.
    Publication type:
    Article
    49
    50